个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Wei, Hongyi[1] * ; Wang, Minghao[1] ; Ou, Jianghua[2] ; Jiang, Weihua[2] ; Tian, Fuguo[3] ; Sheng, Yuan[4] ; Li, Hengyu[4] ; Xu, Hong[5] ; Zhang, Ruishan[5] ; Guan, Aihua[6] ; Wang, Changqing[6] ; Jiang, Hongchuan[7] ; Ren, Yu[8] ; He, Jianjun[8] ; Liu, Jian[9] ; Huang, Weiwei[9] ; Liao, Ning[10] ; Cai, Xiangjun[11] ; Ming, Jia[12] ; Ling, Rui[13] ; Xu, Yan[14] ; Hu, Chunyan[14] ; Zhang, Jianguo[15] ; Guo, Baoliang[15] ; Ouyang, Lizhi[16] ; Shuai, Ping[17] ; Liu, Zhenzhen[18] ; Zhong, Ling[1] ; Jing, Ruilin[19] ; Zeng, Zhen[1] ; Zhang, Meng[19] ; Zhang, Ting[1] ; Xuan, Zhaoling[19] ; Tan, Xuanni[1] ; Liang, Junbin[19] ; Pan, Qinwen[1] ; Chen, Li[1] ; Zhang, Fan[1] ; Fan, Linjun[1] ; Zhang, Yi[1] ; Yang, Xinhua[1] ; Li, Jingbo[1] ; Chen, Chongjian[19,*2] ; Jiang, Jun[1,*1] ;
机构： [1]Department of Breast Surgery, Southwest Hospital, The Third Military Medical University, Chongqing 400038 [2]Department of Breast Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011 [3]Breast Surgery, Shanxi Cancer Hospital, Taiyuan, Shanxi 030013 [4]Department of Thyroid and Breast Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433 [5]Department of Breast Surgery, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning 110042 [6]Department of Breast Surgery, Jilin Cancer Hospital and Institute, Changchun, Jilin 130000 [7]Department of General Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing 100020 [8]Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061 [9]Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian 350014 [10]Breast Department, Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080 [11]Department of Hepatobiliary and General Surgery, PLA No. 202 Hospital, Shenyang, Liaoning 110812 [12]Department of Breast, Thyroid, and Pancreas Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010 [13]Depatement of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Forth Military University, Xi'an, Shaanxi 710032 [14]Department of Breast Surgery, Daping Hospital, Research Institute of Surgery, Third Military Medical University, Chongqing 400038 [15]Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical College, Harbin, Heilongjiang 150086 [16]Department of Breast Surgery, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 4100013 [17]Health Management Center, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072 [18]Department of Breast Surgery, Henan Cancer Hospital, Zhengzhou, Henan 450008 [19]Annoroad Gene Technology (Beijing) Co., Ltd., Beijing 100176, P.R. China
出处：
DOI： 10.3892/ol.2018.8538
ISSN：

关键词： breast cancer BRCA1 BRCA2 chinese population

摘要：
Due to lack of systematic reviews, BRCA, DNA Repair Associated (BRCA) mutations in the Chinese population are not completely understood. The following study investigates the prevalence and type of BRCA mutations in Chinese patients with high hereditary risk of breast cancer (BC). Patients Drwere recruited from 14 cities between October 2015 and February 2016, and were selected based on family and personal medical history. BRCA mutations were analyzed by collecting blood samples from all participants. 437 BC patients were included. A total of seventy-six (17.4%) mutation carriers were identified with no geographic difference. The mutation rate in the early-onset BC patients was lower compared to family history of breast/ovarian cancer (OC), bilateral BC, male BC, BC&OC or meeting >= 2 criteria (9.2 vs. 21.7, 24.0, 22.2, 16.7 and 24.3%, respectively, P=0.007). A total of 61 mutation sites were identified (BRCA1 32, BRCA2 29) including 47.5% novel sites and extra 10 variants of uncertain significance. A total of five sites were repeated in more than one unrelated patient. A total of 11 sites were associated with hereditary breast and ovarian cancer syndrome, two of which were confirmed by family pedigrees. Compared with BRCA-patients, patients with BRCA1 mutation tended to be triple-negative BC (P<0.001), whereas patients with BRCA2 mutation were more likely to be hormone receptor positive BC (P=0.02). The present study provides a general BRCA mutation profile in the Chinese population. The prevalence of BRCA mutation in BC patients with high hereditary risk is lower compared with Western populations. Chinese mutation type is different with Western people, without obvious founder mutation.

基金：
China Health Promotion Foundation
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2018]版：
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版：
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区：
出版当年[2018]版：
Q4 ONCOLOGY
最新[2023]版：
Q3 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者：
第一作者机构： [1]Department of Breast Surgery, Southwest Hospital, The Third Military Medical University, Chongqing 400038
通讯作者：
通讯机构： [1]Department of Breast Surgery, Southwest Hospital, The Third Military Medical University, Chongqing 400038 [19]Annoroad Gene Technology (Beijing) Co., Ltd., Beijing 100176, P.R. China [*1]Department of Breast Surgery, Southwest Hospital, The Third Military Medical University, 30 Gaotanyan Street, Chongqing 400038, P.R. China [*2]Annoroad Gene Technology (Beijing) Co., Ltd., 88 Kechuang Six Street, Beijing 100176, P.R. China
推荐引用方式(GB/T 7714)：
Wei Hongyi,Wang Minghao,Ou Jianghua,et al.Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations[J].ONCOLOGY LETTERS.2018,15(6):9420-9428.doi:10.3892/ol.2018.8538.
APA：
Wei, Hongyi,Wang, Minghao,Ou, Jianghua,Jiang, Weihua,Tian, Fuguo...&Jiang, Jun.(2018).Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.ONCOLOGY LETTERS,15,(6)
MLA：
Wei, Hongyi,et al."Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations".ONCOLOGY LETTERS 15..6(2018):9420-9428

相关文献

[1]Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes [2]Randomized controlled trial of cognitive behavioural therapy for depressive and anxiety symptoms in Chinese women with breast cancer(Open Access) [3]Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients [4]乳腺癌相关成纤维细胞：乳腺癌治疗的新靶点 [5]Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer [6]Estrogen and BRCA1 deficiency synergistically induce breast cancer mutation-related DNA damage. [7]The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients [8]Clinical significance of structural variations in ATM, BRCA1, BRCA2 and RAD51C for Chinese patients with solid tumour [9]Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers [10]Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

资源点击量：53080 今日访问量：0 总访问量：4588 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号